ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991